(CC) Chemours - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1638511089
CC: Pigments, Refrigerants, Resins, Solvents, Coatings, Membranes
Chemours, a spin-off from DuPont, has established itself as a leader in the chemicals industry with a strong foundation inherited from its parent company. Its Titanium Technologies segment, under the Ti-Pure brand, is pivotal in providing essential pigments used across various industries, highlighting the companys role in both traditional and evolving markets.
The Thermal & Specialized Solutions segment addresses environmental regulations, such as the Montreal Protocol, by offering eco-friendly refrigerants and thermal management solutions. This positions Chemours as a key player in the transition to more sustainable technologies, aligning with global efforts to reduce environmental impact.
The Advanced Performance Materials segment showcases Chemours commitment to innovation, supplying high-performance products to industries like electronics and renewable energy. This segment underscores the companys strategic positioning in high-growth sectors, where demand for advanced materials is escalating.
With a global outreach and a diverse distribution network, Chemours efficiently caters to its clientele, ensuring market penetration and customer satisfaction. The companys incorporation in 2014 and headquarters in Wilmington, Delaware, highlight its strategic presence in a key industrial region.
Additional Sources for CC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CC Stock Overview
| Market Cap in USD | 1,587m |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| GiC Sub-Industry | Diversified Chemicals |
| IPO / Inception | 2015-07-01 |
CC Stock Ratings
| Growth Rating | -7.43 |
| Fundamental | -16.8 |
| Dividend Rating | 59.7 |
| Rel. Strength | -51.1 |
| Analysts | 3.44/5 |
| Fair Price Momentum | 10.49 USD |
| Fair Price DCF | - |
CC Dividends
| Dividend Yield 12m | 6.64% |
| Yield on Cost 5y | 11.76% |
| Annual Growth 5y | 0.00% |
| Payout Consistency | 80.9% |
CC Growth Ratios
| Growth Correlation 3m | -94.5% |
| Growth Correlation 12m | -82.5% |
| Growth Correlation 5y | -0.6% |
| CAGR 5y | 5.96% |
| CAGR/Max DD 5y | 0.08 |
| Sharpe Ratio 12m | -1.63 |
| Alpha | -64.07 |
| Beta | 2.007 |
| Volatility | 57.45% |
| Current Volume | 0k |
| Average Volume 20d | 2656.9k |
As of April 19, 2025, the stock is trading at USD 11.36 with a total of 0 shares traded.
Over the past week, the price has changed by +0.71%, over one month by -22.35%, over three months by -41.99% and over the past year by -54.80%.
Neither. Based on ValueRay Fundamental Analyses, Chemours is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -16.79 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CC as of April 2025 is 10.49. This means that CC is currently overvalued and has a potential downside of -7.66%.
Chemours has received a consensus analysts rating of 3.44. Therefor, it is recommend to hold CC.
- Strong Buy: 1
- Buy: 2
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CC Chemours will be worth about 11.3 in April 2026. The stock is currently trading at 11.36. This means that the stock has a potential downside of -0.26%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 21.9 | 92.8% |
| Analysts Target Price | 24.2 | 113.2% |
| ValueRay Target Price | 11.3 | -0.3% |